close

Enter

Log in using OpenID

Infectious Diseases Diagnostics Market

embed
The global market for infectious diseases diagnostics is estimated to reach US$ 876.6 Mn in 2016 from US$ 827.7 Mn in 2015 owing to increasing demand for diagnostic kits caused by rising incidence rate of infectious diseases.
Global Infectious Diseases Diagnostics Market to Represent a Value of US$ 1503.8 Mn
by 2024
According to the latest market report published by Persistence Market Research, titled
“Global Market Study on Infectious Diseases Diagnostics: Increasing Demand for EvidenceBased Treatment to Boost Demand for Infectious Diagnostic Testing during Forecast
Period”. The global market for infectious diseases diagnostics is estimated to reach US$
876.6 Mn in 2016 from US$ 827.7 Mn in 2015 owing to increasing demand for diagnostic
kits caused by rising incidence rate of infectious diseases.
The global infectious disease diagnostics market is expected to reach US$ 1503.8 Mn by
2024. Sexually Transmitted Diseases (STDs) segment is expected to continue to remain the
largest segment by diseases indication accounting for US$ 282.4 Mn in terms of revenue in
2016, a Y – o – Y increase of 7.0% over 2015. The chlamydia diagnostics test kits are
expected to gain upward momentum in 2016, growing at 8.9% in terms of revenue, the
fastest among disease indication segment.
View and Download TOC of Infectious Diseases Diagnostics Market Research Report @
https://www.persistencemarketresearch.com/market-research/infectious-diseasesdiagnostics-market/toc
Cell cultures segment is expected to register highest CAGR in terms of revenue, by test type
accounting for US$ 311.4 Mn in terms of revenue in 2016. The affordability of cell culture
kits and large applications in diagnosis of several infectious diseases is gaining traction.
Consumption demand for cell culture test kits will witness a growth rate of 7.2 % in 2016
over 2015.
Diagnostic centers end user segment is expected to register highest CAGR in terms of
revenue, accounting for US$ 392.8 Mn in terms of revenue in 2016. The increasing number
of diagnostics centers, worldwide and a large number of patient pool depending on
diagnostics centers for diagnosis of infectious diseases is expected to increase demand for
diagnostics tests among diagnostics centers. The diagnostics centers end user segment will
witness a growth rate of 7.4 % in 2016 over 2015.
Request and Download Sample Report @
https://www.persistencemarketresearch.com/samples/11413
Becton, Dickinson and Company, Cepheid, Inc. Abbott Laboratories, bioMérieux SA,
Hologic, Inc., Danaher Corporation, Thermo Fisher Scientific Inc., Roche Diagnostics,
Alere Inc., DiaSorin S.p.A., Quidel Corporation, and Bio-Rad Laboratories, Inc. are key
players in the market. Top players are focusing on developing new products and improving
sensitivity and specificity of the test kits. Collaborations and joint ventures among
manufacturers and local governments are key business strategies being adopted to increase
market share.
PMR Long-term Outlook: PMR projects the global infectious disease diagnostics market to
witness moderate growth during the forecast period 2016–2024. APAC will continue to
remain the largest market for infectious disease diagnostics, registering a CAGR of 7.9%
over the forecast period.
Buy Full Infectious Diseases Diagnostics Market Report @
https://www.persistencemarketresearch.com/checkout/11413
Author
ashutosh
ashutosh164   documents Email
Document
Category
Health and Medicine
Views
4
File Size
34 KB
Tags
diseases, Infectious Disease Diagnostic
1/--pages
Report inappropriate content